C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL

@article{Temesgen2021CREACTIVEPA,
  title={C-REACTIVE PROTEIN AS A BIOMARKER FOR IMPROVED EFFICACY OF LENZILUMAB IN PATIENTS WITH COVID-19: RESULTS FROM THE LIVE-AIR TRIAL},
  author={Zelalem Temesgen and Charles Burger and Jason Baker and Christopher M. Polk and Claudia R. Libertin and Colleen Kelley and Vincent C. Marconi and Robert Michael Orenstein and Victoria M. Catterson and William S. Aronstein and Cameron Durrant and Dale B. Chappell and Gabrielle Chappell and Omar H. Ahmed and Andrew D. Badley},
  journal={Chest},
  year={2021},
  volume={160},
  pages={A2522 - A2524}
}